Weight loss up to 21%!! With GLP-1, which company dominates market? | Oral medication?!! [Eng CC]
😲 The Game Changer for obesity!! Investors must keep an eye on these two companies' stocks.
GLP-1, a hormone that helps regulate appetite in the brain, has been developed into a weight loss medication. The first medication, called Saxenda from Novo Nordisk, has been in use since 2014 and can achieve a maximum weight loss of 5%.
Later developments led to Wegovy, also from Novo, which in 2021 became a "GAME CHANGER" because it can achieve a maximum weight loss of 15%!
But what's even more exciting is what happened last year, in 2023, when Eli Lilly released a new medication called Zepbound. It's a Dual action medication containing both GLP-1 and GIP hormones. Little Zepbound can achieve a maximum weight loss of 21%!! This medication has made waves in both the pharmaceutical and stock markets in the United States!
The future of the pharmaceutical market is expected to grow by 4% annually, so let's keep an eye on the oral medications from Eli Lilly!!
Reference:
https://www.biochempeg.com/article/33...
https://www.nejm.org/doi/full/10.1056...
https://www.nytimes.com/2023/08/17/he...
https://www.frontiersin.org/journals/...
https://www.reuters.com/business/heal...
https://money.usnews.com/investing/ar...
https://www.fiercebiotech.com/biotech...
https://investor.lilly.com/news-relea...
https://pubmed.ncbi.nlm.nih.gov/36050...
https://www.iqvia.com/blogs/2024/02/2...
https://web.musc.edu/about/news-cente...
https://hitconsultant.net/2023/11/06/...
https://www.fastcompany.com/91108767/...
https://www.everydayhealth.com/weight...
#biotechnology #glp1 #obesity #wegovy #zepbound #novonordisk #elililly #pfizer #stocks #ลดความอ้วน #ตลาดหุ้น #usa #อเมริกา #weightloss #ลดน้ำหนัก
00:00 Highlights
00:14 Intro
01:42 Obesity Issues in America
02:26 Weight Loss Medication Market
03:07 Why GLP-1 is Effective for Weight Loss
04:26 GLP-1 Medication from Novo Nordisk
06:15 GLP-1 Medication from Eli Lilly
07:58 Future of Weight Loss Medication
09:23 Precautions in Usage
10:55 Results After Stopping Medication